197 related articles for article (PubMed ID: 21093042)
1. A bioactive self-assembled membrane to promote angiogenesis.
Chow LW; Bitton R; Webber MJ; Carvajal D; Shull KR; Sharma AK; Stupp SI
Biomaterials; 2011 Feb; 32(6):1574-82. PubMed ID: 21093042
[TBL] [Abstract][Full Text] [Related]
2. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis.
Murugesan S; Mousa SA; O'connor LJ; Lincoln DW; Linhardt RJ
FEBS Lett; 2007 Mar; 581(6):1157-60. PubMed ID: 17331505
[TBL] [Abstract][Full Text] [Related]
3. The angiogenic potential of three-dimensional open porous synthetic matrix materials.
Oates M; Chen R; Duncan M; Hunt JA
Biomaterials; 2007 Sep; 28(25):3679-86. PubMed ID: 17517430
[TBL] [Abstract][Full Text] [Related]
4. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
5. Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay.
Azzarello J; Ihnat MA; Kropp BP; Warnke LA; Lin HK
Biomed Mater; 2007 Jun; 2(2):55-61. PubMed ID: 18458436
[TBL] [Abstract][Full Text] [Related]
6. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.
Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X
Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of VEGF-and bFGF-loaded alginate oxide particles in acellular collagen-alginate composite hydrogel to promote angiogenesis.
Azarpira N; Kaviani M; Sarvestani FS
Tissue Cell; 2021 Oct; 72():101539. PubMed ID: 33838351
[TBL] [Abstract][Full Text] [Related]
8. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels.
Zieris A; Chwalek K; Prokoph S; Levental KR; Welzel PB; Freudenberg U; Werner C
J Control Release; 2011 Nov; 156(1):28-36. PubMed ID: 21763368
[TBL] [Abstract][Full Text] [Related]
9. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
10. The chick chorioallantoic membrane as an in vivo angiogenesis model.
Ponce ML; Kleinmann HK
Curr Protoc Cell Biol; 2003 May; Chapter 19():Unit 19.5. PubMed ID: 18228425
[TBL] [Abstract][Full Text] [Related]
11. The effect of heparinized decellularized scaffolds on angiogenic capability.
Wu Q; Li Y; Wang Y; Li L; Jiang X; Tang J; Yang H; Zhang J; Bao J; Bu H
J Biomed Mater Res A; 2016 Dec; 104(12):3021-3030. PubMed ID: 27459086
[TBL] [Abstract][Full Text] [Related]
12. Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
J Control Release; 2006 Nov; 116(2):e88-90. PubMed ID: 17718989
[No Abstract] [Full Text] [Related]
13. Insulin induces the expression of FGF2 but does not synergize with it during angiogenesis.
Krishnapati LS; Ghaskadbi S
Microvasc Res; 2016 Jan; 103():55-63. PubMed ID: 26549747
[TBL] [Abstract][Full Text] [Related]
14. Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo.
Bai Y; Leng Y; Yin G; Pu X; Huang Z; Liao X; Chen X; Yao Y
Cell Tissue Res; 2014 Apr; 356(1):109-21. PubMed ID: 24442492
[TBL] [Abstract][Full Text] [Related]
15. Heparin binding chitosan derivatives for production of pro-angiogenic hydrogels for promoting tissue healing.
Yar M; Shahzad S; Shahzadi L; Shahzad SA; Mahmood N; Chaudhry AA; Rehman IU; MacNeil S
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():347-356. PubMed ID: 28254303
[TBL] [Abstract][Full Text] [Related]
16. In ovo leptin administration inhibits chorioallantoic membrane angiogenesis in female chicken embryos through the STAT3-mediated vascular endothelial growth factor (VEGF) pathway.
Su L; Rao K; Guo F; Li X; Ahmed AA; Ni Y; Grossmann R; Zhao R
Domest Anim Endocrinol; 2012 Jul; 43(1):26-36. PubMed ID: 22417645
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor and vascular endothelial growth factor play a critical role in endotheliogenesis from human adipose-derived stem cells.
Khan S; Villalobos MA; Choron RL; Chang S; Brown SA; Carpenter JP; Tulenko TN; Zhang P
J Vasc Surg; 2017 May; 65(5):1483-1492. PubMed ID: 27514438
[TBL] [Abstract][Full Text] [Related]
18. Synthetic oligosaccharide stimulates and stabilizes angiogenesis: structure-function relationships and potential mechanisms.
Mousa SA; Feng X; Xie J; Du Y; Hua Y; He H; O'Connor L; Linhardt RJ
J Cardiovasc Pharmacol; 2006 Aug; 48(2):6-13. PubMed ID: 16954815
[TBL] [Abstract][Full Text] [Related]
19. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
20. Fibrin-based biomaterials to deliver human growth factors.
Wong C; Inman E; Spaethe R; Helgerson S
Thromb Haemost; 2003 Mar; 89(3):573-82. PubMed ID: 12624643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
